[ad_1]
Sai Life Sciences is one of India’s fastest growing Contract Research, Development & Manufacturing Organizations. As a pure-play, full-service CRO-CDMO, we work with over a 100 global innovator pharma and biotech companies to accelerate the discovery, development, and commercialisation of their NCE small molecule programmes. Over the past two decades, Sai Life Sciences has served a diverse set of programmes, consistently delivering value based on its quality and responsiveness. Today, it has over 2000 employees across its facilities in India, UK and USA.
Sai Life Sciences delivers advanced Discovery, Contract Development and Manufacturing Solutions, through a broad suite of expert capabilities across the molecular lifecycle. Interested and eligible candidates can attend interview on scheduled time and venue.
Walk in Details :
- Company Name: Sai Life Sciences Ltd
- Location : Bidhar
- Positions: Chemist
- Department: Analytical R&D
- Qualification: M.Sc / M.Pharm
- Experience: 01 to 06 years
Date : 21st Aug’ 2022,
Time: 9AM to 2PM,
Sai life Sciences, 4th Floor, SLN Terminus, Gachibowli, Hyderabad
Interested candidates share your resume to hemalatha.s@sailife.com
Sai Life Sciences delivers advanced Discovery, Contract Development and Manufacturing Solutions, through a broad suite of expert capabilities across the molecular lifecycle. Interested and eligible candidates can attend interview on scheduled time and venue.
Walk in Details :
- Company Name: Sai Life Sciences Ltd
- Location : Bidhar
- Positions: Chemist
- Department: Production – API
- Qualification: B.Tech, M.Sc / B.Sc Chemistry, Diploma
- Experience: 01 to 03 years
Date : 21st Aug’ 2022,
Time: 9AM to 2PM,
Venue:
Sai life Sciences, 4th Floor, SLN Terminus, Gachibowli, Hyderabad
Interested candidates share your resume to tacorp@sailife.com
More Job Updates Join What’s App Group – Click Here
Join Telegram Group – Click Here
[ad_2]
Source link
Comments
0 responses to “Sai Life Sciences Ltd – Walk-In Interviews for Analytical R&D / Production on 21st Aug’ 2022”
Comments